Ameriprise Financial Inc Oncocyte Corp Transaction History

Ameriprise Financial Inc

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.2 - $0.35 $460 - $805	2,300 Added 5.42%	44,700 $10,000
Q1 2023 May 15, 2023	SELL	$0.2 - $0.49 $100 - $245	-500 Reduced 1.17%	42,400 $14,000
Q4 2022 Feb 14, 2023	SELL	$0.25 - $15.6 $750 - $46,800	-3,000 Reduced 6.54%	42,900 $13,000
Q3 2022 Nov 14, 2022	BUY	$0.76 - $15.98 $24,396 - $512,958	32,100 Added 232.61%	45,900 $34,000
Q2 2022 Aug 15, 2022	SELL	$0.86 - $1.53 $111 - $198	-130 Reduced 0.93%	13,800 $12,000
Q1 2022 May 16, 2022	BUY	$1.15 - $2.25 $299 - $585	260 Added 1.9%	13,930 $21,000
Q4 2021 Feb 14, 2022	SELL	$2.04 - $3.59 $204 - $359	-100 Reduced 0.73%	13,670 $30,000
Q3 2021 Nov 15, 2021	BUY	$3.53 - $5.89 $48,608 - $81,105	13,770 New	13,770 $49,000
Q1 2021 May 17, 2021	SELL	$2.39 - $6.5 $163,643 - $445,055	-68,470 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$1.38 - $2.63 $696 - $1,328	-505 Reduced 0.73%	68,470 $164,000
Q3 2020 Nov 16, 2020	BUY	$1.2 - $1.89 $474 - $746	395 Added 0.58%	68,975 $96,000
Q2 2020 Aug 14, 2020	SELL	$1.91 - $3.45 $2,865 - $5,175	-1,500 Reduced 2.14%	68,580 $131,000
Q1 2020 May 15, 2020	BUY	$1.76 - $3.02 $2,763 - $4,741	1,570 Added 2.29%	70,080 $172,000
Q4 2019 Feb 14, 2020	SELL	$1.51 - $2.27 $453 - $681	-300 Reduced 0.44%	68,510 $154,000
Q3 2019 Nov 14, 2019	BUY	$1.59 - $2.51 $2,400 - $3,790	1,510 Added 2.24%	68,810 $145,000
Q1 2019 May 15, 2019	BUY	$1.47 - $5.91 $98,931 - $397,743	67,300 New	67,300 $266,000

411K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $260M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.